Recombinant Human MT2 Protein，His

MT2 (metallothionein 2) is a low-molecular-weight, cysteine-rich protein that plays a crucial role in metal ion homeostasis, detoxification, and cellular defense mechanisms. It is part of a larger family of metallothioneins, which are known for their ability to bind heavy metals such as zinc, copper, and cadmium, thereby protecting cells from metal toxicity and oxidative stress. Research on MT2 has gained significant attention due to its involvement in various physiological processes and its potential implications in health and disease. Studies indicate that MT2 is not only vital for maintaining metal balance in cells but also influences critical pathways such as cell proliferation, apoptosis, and immune response. Alterations in MT2 expression have been associated with several pathological conditions, including cancer, neurodegenerative diseases, and inflammatory disorders, making it an important biomarker for disease diagnosis and prognosis. Moreover, the modulation of MT2 expression presents potential therapeutic avenues, as enhancing its function could protect against metal-induced damage and promote cellular resilience. Understanding the molecular mechanisms governing MT2's role in these processes is essential for developing targeted interventions and advancing our knowledge of cellular defense systems. As research continues, MT2 and its recombinant forms are being explored for therapeutic applications, including in the fields of biomedicine and biotechnology, highlighting its significance in both fundamental and applied sciences.